The Russian Federation sent the first Nordion medical isotope sample.

Ottawa, December of 2010. “Nordion Inc., a leading provider of products and services for the global market of the health sciences, announced last Thursday that it has sent its first sample of molybdenum-99 (Mo-99) from its partner of the Russian Federation, the company open joint Isotope values” (Isotope).

In September 2010 Nordion reached an Isotope supply agreement for carrying out residual Mo-99 supply until the year 2020. This recent sample of Mo-99 will be evaluated in Ottawa, Canada processing facilities. It is necessary to get the part of qualification for the registration of the product and regulatory approvals process before that company begins to receive the supply of the distribution of license.

“The sending of this first exhibition of Mo-99 is a key achievement in our Isotope supply agreement.” “In collaboration with Isotope, we hope complete the evaluation and advance supply customers with greater stability in its chain of supplies,” said Jill Chitra, senior Vice President of quality and regulatory affairs of Nordion. “We are planning to receive supplies for shipment in the first half of fiscal 2011 year, still scheduled arrival time to help mitigate the impact of the stop of reactor National Research Universal (NRU), expected by the middle of the month of May 2011.”

The Mo-99 Nordion with Isotope supply agreement provides a supply of support for customers of the company, and is expected to improve the reliability of the company’s supply chain

Preparation for shipment of the first samples, the Government of the Russian Federation and Rosatom State Corporation have invested in new and existing infrastructure. December 18, 2010, began the first production line for Mo-99 at Atomic assessment Research Institute of Dimitrovgrad, Russia.

“The release of this production complex is an outstanding event.” “The combination of a production modern radiochemical with several reactors in a unique facility provides an uninterrupted supply of isotopes for the future,” commented Andrey Silkin, CEO of Isotope. “With one growing population and a growing demand for diagnosis, the moment of appearance of our supply in the market fits perfectly with the world needs”.

Doctors use medical isotopes to achieve a better diagnosis and treatment of several diseases, including heart and neurological diseases, and various types of cancer. According to the World Nuclear Association, over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of procedures are for diagnosis. MO – 99, and more specifically the isotope medical derived technetium – 99 m is used in approximately 80% of nuclear medical procedures around the world, up to 70,000 every day.

About Nordion

Nordion Inc. (TSX: NDN;) NYSE: NDZ) is a company of the health sciences global products and leading services in the market for the prevention, diagnosis and treatment of disease. We are a leading supplier of innovative technologies for use in medical imaging and radiation therapy, and sterilization technologies that benefit the lives of millions of people in more than 60 countries around the world. Our products and services are used daily by the biotechnology and pharmaceutical companies, manufacturers of medical devices, hospitals, clinics and laboratories of research Nordion has more than 360 staff highly qualified in four locations.

About Rosatom

Rosatom, the State Atomic Energy Corporation, is the main utility of Russia company, and produces more than 40% of the electricity in Western Russia. Rosatom is in first place in the construction of nuclear reactors worldwide, in second place in reserves of uranium and fourth position in nuclear energy generation, which provides 40% of global uranium enrichment services and 17 per cent of the global nuclear fuel fabrication. Rosatom became a State company in the year 2007, and currently consists of more than 250 companies and scientific institutions in Russia, including civilian nuclear companies, research organizations, and the only nuclear naval fleet in the world.

about the open company of joint values “Isotope” (Isotope or JSC Isotope)

service provides Isotope as a link between the isotopes of Rosatom and end-users in the markets of Russia producer and international. The main areas of activity of Isotope include: supply of isotopes for domestic and international markets; sales and marketing of products, instruments and devices for medical and commercial use; issues related to the safety of radiation and isotope technology development.